News Features ‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry Michael O'Riordan January 10, 2020
News Conference News AHA 2019 Sex Differences, EF Thresholds Probed for Sacubitril/Valsartan in Heart Failure Shelley Wood November 22, 2019
News Daily News Dapagliflozin Gets Expanded Indication for Prevention of HF Hospitalization in Type 2 Diabetes L.A. McKeown October 21, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2019 Shelley Wood October 01, 2019
News Conference News ESC 2019 PARAGON-HF Misses Primary Endpoint, but Hints of Benefit Seen Todd Neale September 01, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations L.A. McKeown April 23, 2019
News Conference News ACC 2019 New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin Shelley Wood March 26, 2019
News Daily News How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting Shelley Wood February 26, 2019
News Industry News Corvia Medical Announces Strong Positive One-Year Data From Reduce LAP-HF I Randomized, Sham-Controlled Clinical Trial August 27, 2018
News Daily News Low BP Tied to Poor Outcomes in Hospitalized Patients With HFpEF Todd Neale February 20, 2018
News Conference News AHA 2017 Novel Interatrial Shunt Succeeds in HF Hemodynamic Study: REDUCE LAP-HF I Michael O'Riordan November 21, 2017
News Conference News AHA 2016 Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF Shelley Wood November 16, 2016
News Industry News Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study May 12, 2016
News Industry News Mast Therapeutics Announces Positive Top-Line Results From Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) Conducted At Mayo Clinic January 31, 2016
News Industry News DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical June 22, 2015